Beginner's Mind
Blueprints for Builders and Investors
Hosted by Christian Soschner
From pre-seed to post-IPO, every company lives or dies by the frameworks it follows.
On Beginner’s Mind, Christian Soschner uncovers the operating principles behind the world’s most successful companies—through deep-dive interviews, strategic book reviews, and patterns drawn from history’s greatest business, military, and political leaders.
With 35+ years across M&A, company building, board roles, business schools, ultrarunning, and martial arts, Christian brings a rare lens:
What frameworks actually work at each stage of scale—especially in complex deep tech sectors like biotech and AI—and how to implement them to build durable, high-value companies.
🎙 Expect each episode to deliver:
- Founder & Investor Blueprints: Real-world lessons from biotech, deep tech, and beyond—from Series A to IPO
- Historical & Biographical Frameworks: Actionable insights from the playbooks of giants
- Operating Clarity: No fluff—just what moves the needle
Whether you're leading a company, scaling one, or investing in the next great one—this podcast gives you the strategic edge.
Listen in. Apply what matters. Build companies that last.
📬 Join the newsletter & community: https://lsg2g.substack.com/
Beginner's Mind
MM 17: Daniel Vitt: Munich's Biotech Surge: The Untold Story Behind Europe's Innovation Hub
Munich, Bavaria - a picturesque city known for its rich history and Oktoberfest. But did you know it's also the epicenter of Europe's biotech revolution? Dive into this captivating conversation with Dr. Daniel Vitt, the driving force behind Immunic Therapeutics, as he unravels the secrets of Munich's meteoric rise in the biotech realm.
1️⃣ Munich's Meteoric Rise:
Discover how Munich transformed into one of Europe's most dynamic biotech ecosystems, and the role of visionary political decisions in its ascent.
2️⃣ Inside Immunic's Journey:
From its inception to its transformative stages, journey with Dr. Vitt as he shares the challenges and triumphs of leading a biotech giant. Learn about Immunic's groundbreaking developments and its innovative approach to treating diseases like multiple sclerosis.
3️⃣ About Dr. Daniel Vitt:
Dr. Daniel Vitt, CEO of Immunic Therapeutics, is a biotech luminary with a rich legacy, including co-founding 4SC AG. His insights offer a rare glimpse into the intricacies of the global biotech landscape, from Europe to the US.
Full Episode
📢 Engage with Us:
If this narrative resonates with you, please subscribe, like, comment, and share. Your support amplifies our voice, bringing more such enlightening tales to the forefront.
🎉 Dive In:
Embark on this enlightening journey into the world of biotech innovation. Let's explore the stories of those shaping our tomorrow.
Join the Podcast Newsletter: Link
